No Data
No Data
Canada Net Change Percentage Gainers & Losers
Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic & Anal Cancers
Oncolytics Biotech to Present "Promising" Pelareorep Data at ASCO GI Symposium
Oncolytics Biotech Unveils Promising Cancer Therapy Results
Express News | Oncolytics Biotech Reveals Presentation Of Two Data Sets Through Two Abstracts Showcasing Pelareorep's Potential In Difficult-to-treat Gastrointestinal Cancers At ASCO
Oncolytics Biotech Competes Safety Phase Enrollment for GOBLET Trial's Pancreatic Cancer Cohort